Practice Areas

Patent

Trademark

Technology Areas

Biotechnology and Drug Discovery

Organic Chemistry and Pharmaceuticals

Mechanical and Medical Devices

Instrumentation and Microfluidics

Bar Admissions

State Bar of California

U.S. Patent and Trademark Office

Phone: (858) 587-2510

email: Ray@BiotechBeachLaw.com

Professional Experience

Raymond Wagenknecht is a patent attorney licensed by the United States Patent and Trademark Office and the State of California. He counsels clients on all aspects of IP-related matters including preparation and prosecution of patent applications, noninfringement opinions, patent and technology licensing, IP litigation, infringement analysis and due diligence investigations.

Raymond’s background includes preparation and prosecution of U.S. and PCT international patent applications for life science technologies including biotechnology, medical devices, organic compounds, pharmaceuticals and more. Scientific areas of particular experience include:

• Cell therapies (e.g. stem cells)
• Cancer (e.g. prostate, hepatocellular)
• Steroid associated disorders (e.g. acne, alopecia)
• Allergy (e.g IgE mediated conditions)
• Cardiovascular dissorders (e.g. atherosclerosis, restenosis, hypoxia, anoxia)
• Diabetes (e.g. glucose detection)
• Immunoassays (e.g. analyte test strips)
• Renal disorders (e.g. dialysis)
• Instrumentation (e.g. micfabricated biochips)
• Aquaculture
• And more

Prior to becoming a patent attorney, Raymond worked as a researcher within the Department of Medicine of the University of California, San Diego and with a start-up drug discovery company. Raymond is a co-author on five (5) life science research papers in the fields of immunology and electrophoresis (listed below).

Professional Memberships

Raymond Wagenknecht is an active member of the Biotechnology committee and Nanotechnology committee of the American Bar Association, and the San Diego Intellectual Property Law Association.

Scientific Publications

"A B Cell Superantigen-induced Persistent 'Hole' in the B-1 Repertoire"
G.J. Silverman, S. Cary, D. Dwyer, L. Luo, R. Wagenknecht and V.E. Curtiss.
J. Exp. Med., 2000 Jul 3;192(1):87-98.

"Characterization of Superantigen-Induced Clonal Deletion with a Novel Clan III-Restricted Avian Monoclonal Antibody: Exploiting Evolutionary Distance to Create Antibodies Specific for a Conserved VH Region Surface"
Cary SP, Lee J, Wagenknecht R, Silverman GJ
J. Immunol., 2000 May 1;164(9):4730-41

"Improved two-dimensional gel electrophoresis representation of serum proteins using ProtoClear™"
Lollo BA, Harvey S, Liao J, Stevens AC, Wagenknecht R, Sayen R, Whaley J, Sajjadi FG.
Electrophoresis, 1999 Apr-May;20:854-9

“In Vivo Consequences of a B-Cell Superantigen Immunization”
Gregg J. Silverman, Jayakar Nayak, Raymond Wagenknecht, Klaus Warnatz.
Ann. N.Y. Acad. Sci., 1997 Apr 5;815:105-110

"A B-Cell Superantigen That Targets B-1 Lymphocytes"
Silverman GJ, Cary S, Graille M, Curtiss VE, Wagenknecht R, Luo L, Dwyer D, Goodyear C, Corper AL, Stura EA, Charbonnier JB
Curr Top Microbiol Immunol. 2000;252:251-63

Education

Raymond graduated from the University of San Diego, School of Law (USD) and from the University of California, San Diego (UCSD) where he earned a B.S. in Molecular Biology. He attended San Diego State University (SDSU) for a M.S. in Organic Chemistry where he presented seminars in medicinal chemistry and biochemistry.

sitemap